15 results
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Guidelines - ... Aspergillosis #Treatment #pharmacology ... #medications #IDSA ... #Guidelines
Doses of Antituberculosis Drugs for Adults and Children - IDSA
First-line drugs:
 ā€¢ Isoniazid
 ā€¢ Rifampin
 ā€¢
Antituberculosis Drugs ... and Children - IDSA ... First-line drugs ... #Tuberculosis #Drugs ... Medications #management #pharmacology
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Tuberculosis - IDSA ... Guidelines # ... #medications #pharmacology ... #IDSA #Guidelines
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... antimicrobials #pharmacology ... #dosing #idsa # ... drugs
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
fluoroquinolone #IDSA ... Regimen #Management #Guidelines ... #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 ā€¢
IDSA - Clinical ... Regimen for Multi-Drug ... antimicrobials #regimens #pharmacology ... #dosing #idsa # ... drugs #steps
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
of the 3 main drug ... Though drug name ... combinations of these drug ... Guideline recommendations ... Classes #DAAs #Pharmacology
Paxlovid Drug-Drug Interactions
Before prescribing ritonavir-boosted nirmatrelvir (Paxlovid) for outpatient treatment of COVID-19, determine whether the patient
Paxlovid Drug-Drug ... files.covid19treatmentguidelines.nih.gov/guidelines ... #nirmatrelvir #Drug ... Interactions #DDI #pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... Inhibitor GOLD 2019 Guideline ... 2019 COPD GOLD guidelines ... exacerbations. 2019 GOLD guidelines ... #Indications #Pharmacology
IDSA 2017 CDiff Guidelines - TableĀ 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... infection Episode #Pharmacology